Sera Prognostics (SERA) Common Equity (2020 - 2026)
Sera Prognostics' (SERA) quarterly Common Equity came in at $67.6 million in Q1 2026, down 28.66% YoY from $94.8 million in Q1 2025, and down 10.33% on a QoQ basis from $75.4 million in Q4 2025.
Sera Prognostics (SERA) Common Equity (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Common Equity data on file, last reported at $67.6 million in Q1 2026.
- Quarterly Common Equity fell 28.66% year-over-year to $67.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.6 million (down 28.66% YoY) and the FY2025 annual result came in at $75.4 million, up 57.75% from the prior year.
- Common Equity fell to $67.6 million in Q1 2026, from $75.4 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $127.2 million in Q1 2022 to a low of $47.8 million in Q4 2024.
- A 5-year average of $82.5 million and a median of $81.1 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity jumped 197.56% — and 2024, when it plunged 31.86%.
- Tracing SERA's Common Equity over 5 years: stood at $98.9 million in 2022, then declined by 29.09% to $70.2 million in 2023, then sank by 31.86% to $47.8 million in 2024, then soared by 57.75% to $75.4 million in 2025, then fell by 10.33% to $67.6 million in 2026.
- The last three Common Equity figures came in at $67.6 million (Q1 2026), $75.4 million (Q4 2025), and $82.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 59.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.38 Mn |
| Mar 31, 2026 | 67.62 Mn |
| Dec 31, 2025 | 75.41 Mn |
| Sep 30, 2025 | 82.18 Mn |
| Jun 30, 2025 | 88.23 Mn |
| Mar 31, 2025 | 94.78 Mn |
| Dec 31, 2024 | 47.80 Mn |
| Sep 30, 2024 | 54.65 Mn |
| Jun 30, 2024 | 59.75 Mn |
| Mar 31, 2024 | 64.75 Mn |
| Dec 31, 2023 | 70.16 Mn |
| Sep 30, 2023 | 75.41 Mn |
| Jun 30, 2023 | 81.14 Mn |
| Mar 31, 2023 | 90.21 Mn |
| Dec 31, 2022 | 98.94 Mn |
| Sep 30, 2022 | 107.16 Mn |
| Jun 30, 2022 | 116.91 Mn |
| Mar 31, 2022 | 127.20 Mn |
| Dec 31, 2021 | 138.56 Mn |
| Sep 30, 2021 | 150.04 Mn |